This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk01: Hello, everyone, and welcome to Spoke Holdings' Fourth Quarter Earnings and Strategic Plan Call. I am joined by Vince Kelly, President and Chief Executive Officer, as well as Michael Wallace, Chief Financial Officer and Chief Operating Officer. I would like to remind everyone that today's conference call may include forward-looking statements that are subject to risks and uncertainties related to Spoke's future financial and business performance. Such statements may include estimates of revenue, expenses, and income, as well as other predictive statements or plans which are dependent upon future events or conditions. These statements represent the company's estimates only on the date of this conference call and are not intended to give any assurance as to the actual future results. Folks' actual results could differ materially from those anticipated in these forward-looking statements. Although these statements are based on assumptions that the company believes to be reasonable, They are subject to risks and uncertainties. Please review the risk factor section relating to our operations and the business environment in which we compete contained in our 2021 Form 10-K and related documents we expect to file with the Securities and Exchange Commission. Please note that SPOKE assumes no obligation to update any forward-looking statements from past or present filings and conference calls. With that, I'll turn the call over to Vince.
spk05: Thank you. Let's turn to slide three, and good morning, everyone. Thanks for joining us for this important update. Today we will share with you how we plan to deliver significant shareholder value with our new strategic business plan. As stated in our press release this morning, our plan will prioritize in maximizing free cash flow and returning capital to shareholders, while at the same time continuing to explore alternatives to our ongoing strategic review process. I'll start by reviewing the agenda for today's call. The order will be as follows. We'll start with a high level overview of our fiscal year 2021 results. Next, we'll review a summary of our new strategic business plan. This will include our capital allocation decisions and prioritization of returning capital to shareholders. Then we'll cover our current outlook for 2022 and 2023. And finally, We'll conclude with a wrap-up and Q&A session. Turning to slide four, as mentioned, before we begin our discussion of the new strategic business plan for SPOKE, I'd like to take a few minutes and provide a recap of our 2021 financial performance, which we reported earlier this morning. I encourage you to review our 10-K when filed, as it contains significantly more information about our business operations and financial performance than we will cover on this call. For fiscal year 2021, we achieved our previously communicated full-year financial guidance for revenue, adjusted operating expenses, and capital expenditures. Total gap revenue for fiscal year 2021 was $142.2 million, consisting of wireless revenue of $78.8 million and software revenue of $63.3 million. With respect to wireless revenue, 2021 performance was driven by a lower level of pager unit churn on a year-over-year basis. In fact, net pager churn decline during the year averaged 4.3%, another record low. As a result, wireless revenue for 2021 remained solid, declining only 5.7% compared to the prior year. These continued strong trends in our wireless business are being driven by the combination of solid gross additions from our sales organization continued minimization of churn with existing customers, and stable unit pricing. Furthermore, in future periods, we expect our new Gen A pager, which was announced in November 2021, to be a significant factor in minimizing churn and maintaining average revenue per unit. For software revenue, 2021 performance of $63.3 million represented a 2% decrease from 2020. Given the slow adoption of SpokeGo due in part to the pandemic and its impact on our customers' resources, virtually all software revenue is related to our legacy CareConnect Suite solutions. A relatively flat revenue performance in 2021 on a year-over-year basis resulted from a combination of several factors, including, number one, the fact that our focus had been on bringing SpokeGo to market rather than our CareConnect Suite solutions. And this is going to change going forward. Number two, hospital customers, our largest segment, have continued to struggle with significant burnout and resource constraints due to the pandemic. The U.S. healthcare system has lost between one in five to one in six healthcare workers. Nursing staff have been significantly depleted. On average, it takes four to five years to train a nurse. We expect these resource constraints to last well into the future. And while we've had success over the past year, selling our CareConnect Suite solutions, our ability to demonstrate, sell, and install our completely new cloud native clinical communication solutions, SpokeGo, was severely impacted. Number three, our software maintenance revenue is a critical source of our reoccurring revenue stream. 2021 software maintenance revenue was 38 million versus 38.6 million in 2020, or 1.6% lower. As we've discussed previously, maintenance revenue being flat, slightly down, is in line with our expectations, given gross churn and uplift levels remaining consistent with prior years, combined with less net additions through bookings, primarily due to our 2021 focus on SpokeGo versus our CareConnect suite. For the full year 2021, adjusted operating expenses, which excludes depreciation, amortization, accretion, goodwill and capitalized software development impairment charges and severance and restructuring charges and includes capitalized software development costs totaled $154.3 million. Additionally, we incurred approximately $2 million in costs related to our strategic alternatives review process. Expense management going forward will be a major focus as we align expense levels with market demand for our products. In 2021, both operating expenses and adjusted operating expenses were up from the prior year levels. However, the year-over-year comparisons are difficult given the timing of furloughs, CARES Act reimbursement, costs related to our strategic alternatives review process, and other costs. Despite this, for 2021, we reported adjusted operating expenses of $154.3 million, up from $147.3 million in the same period a year ago. Adjusted operating expenses were higher largely as a result of the following three items. One, we incurred approximately $3.8 million of higher payroll and related costs in 2021 as compared to the same period a year ago. Employees incurred two weeks of furlough last year as opposed to five in 2020. We also experienced increased healthcare costs as many individuals delayed wellness visits and medical procedures with lockdowns in place during 2020. Our average employee compensation costs increase, particularly for software engineering talent. The healthcare technology market continues to see low unemployment as well as tougher competition for employee recruiting and retention combined with the market's adoption of a remote working environment. This has broadened the reach of many larger companies with which we compete for talent. Number two. 2020 included approximately $1.3 million of one-time savings related to refundable tax credits for employee retention taken under the CARES Act. And number three, as mentioned previously, we incurred approximately $2 million in costs related to our strategic alternatives review process. Each of the items described above, with the exception of the $2 million in process costs, were reflected in our financial guidance. Additionally, in the fourth quarter of 2021, We recorded an impairment charge of $15.7 million related to capitalized research and development costs associated with SpokeGo. Finally, our balance sheet remains strong with a cash, cash equivalents, and short-term investment balance of $59.6 million as December 31st, 2021. We continue to operate as a debt-free company. Let's turn to slide five. And I'd like to now provide an update on our previously announced strategic review process. As you'll recall, the process commenced last year whereby the board, in partnership with management and our financial and legal advisors, began evaluating alternatives to maximize shareholder value. After a comprehensive and rigorous process, the company today is announcing a new strategic business plan, one that prioritizes maximizing cash flow over the long term and returning capital to shareholders. Consistent with our announcement this morning, our Board of Directors has unanimously approved this business plan, which we will begin to implement immediately. The plan includes maximizing revenue and cash flow generation from our established Spoke CareConnect suite, including Spoke Mobile, and our wireless service offerings. As a reminder, Our company has an excellent track record of driving revenue from these business lines and enjoys a significant market leadership position in narrowband personal communication services, i.e. paging, and hospital call center solutions. Additionally, we plan to invest in a targeted and limited manner in these important and valuable franchises in order to continue our longstanding relationships with the nation's leading healthcare providers. While this has been a difficult decision, the company will be discontinuing SpokeGo and intends to eliminate all associated costs. Ultimately, the ongoing challenge of the COVID-19 pandemic has made it untenable for the platform to gain significant traction with customers or for our business to continue operating with our current levels of costs and personnel. Given the environment in which we operate with respect to both the health of our customer base and the challenges in software engineering talent retention and acquisition, We believe this is the best path forward for Spoke and our shareholders. With that being said, we will continue to work closely with existing Spoke Go customers to ensure that this transition is as smooth as possible. Our new strategic business plan also includes expanding on the company's already disciplined expense management by streamlining our management structure, rationalizing external costs, reducing capital expenditures, and consolidating offices. Proceeding down this course involves some very hard decisions. We will be trimming our management team by roughly one half and we'll be reducing our workforce by approximately one third over the course of the next 60 days. We are not taking these steps lightly. However, after careful deliberation and given the challenges that we have talked about, we believe this is the right decision. I'd also like to note that our review of strategic alternatives remains ongoing. While this process has not yet resulted in a transaction, the Board remains open to all potential alternatives to maximize value. Let's look at slide six. Turning now to the company's plans to prioritize returning capital to our shareholders, SPOKE will be increasing our regular quarterly dividend by 150%, from 12.5 cents per share, or 50 cents annually, to 31.25 cents per share, or $1.25 annually. This increased dividend was approved by our board, and a quarterly dividend was declared with a record date of March 16, 2022, and a payment date of March 30, 2022. Based on our new business plan and our view of the future, we believe we can continue to pay this level of dividend for the foreseeable future and expect to be able to fund the majority of it from cash flow from operations in 2023 and beyond. This new level of dividend represents a significant and recurring yield on spoke shares going forward. As always, the declaration and payment of future dividends is subject to the Board's discretion and will depend on financial and legal requirements and other considerations. Additionally, the Board has also authorized a share repurchase program of up to $10 million of the company's common stock. This authorization allows the company to return capital to shareholders by opportunistically repurchasing the company's shares. We'll continue to evaluate opportunities to repurchase shares as SPOKE transitions throughout our strategic pivot underway during 2022. And finally on this subject, we'll continue to evaluate our capital allocation strategy with the goal of maximizing shareholder value while continuing to provide critical communication services to our very important healthcare communications customers. I'll now turn the call over to Michael Wallace, our Chief Financial Officer and Chief Operating Officer, who will review our financial outlook for 2022 and 2023. Mike?
spk04: Thanks, Vince, and good morning, everyone. I'm turning to slide seven. So as Vince went through our 2021 results and took you through the strategic pivot that we are embarking on today, I would like to take some time to give you our thoughts for the balance of this year and looking into 2023. And before getting into specifics, I think it is important to highlight for everyone that fiscal year 2022 will be a transition year for SPOKE, given the implementation time required to execute our strategic shift to a cash flow model. However, we do anticipate that this transition will be completed by the end of 2022. So turning to our guidance for 2022, and be reminded the figures I am going to discuss today are included in our guidance table in the earnings release. We expect total revenue to be in the range of 126 million to 139.2 million, of which we expect wireless revenue to range between 71.6 million to 77 million, where the midpoint reflects an annual revenue attrition rate of approximately 5.7%, when compared to 2021 and is consistent with our recent trends. Software revenue is expected to range from $54.4 million to $62.2 million, where the midpoint reflects annual revenue attrition of approximately $5 million from 2021. Given that, it is important to understand where this decrease in total software revenue from 2021 is coming from and why. First, we have assumed an intentional reduction in services revenue to better align with our current backlog and to drive a higher rate of net cash flow in alignment with the shift in our strategic business plan that Vince previously mentioned. Services has not historically driven meaningful cash flow on a standalone basis, but has been viewed as an opportunity to expand our license footprint through customer engagement, as well as to fulfill upgrade obligations under our maintenance contracts, which is critical to maintaining our existing customers. Second, an anticipated low point in CareConnect Suite bookings in 2022, which will impact license and equipment revenue, which typically has revenue recognition immediately as we focus solely on CareConnect Suite across the organization and bolster our CareConnect Suite product line through directed R&D spend at levels consistent with previous years in the $7 million to $9 million range annually without the dilutive effects from SpokeGo initiatives. And third, for maintenance revenue to contract by approximately 3% on a year-over-year basis, primarily due to the lower net additions provided by bookings in 2022 that I just discussed, as we expect customer churn and annual uplift rates to remain consistent with past years. Turning to adjusted operating expenses, we expect adjusted operating expenses for the full year of 2022 to be in the range of $118.8 million to 128.6 million. As noted in our earnings release, adjusted operating expenses exclude severance, restructuring costs, depreciation, amortization, and accretion. And regarding the one-time costs, I will speak to those specific costs on the next slide. But first, as it relates to adjusted operating expenses, the reduction from the 154.3 million in 2021 to the 2022 midpoint of 123.7 million or approximately $30 million lower is as follows. First, the majority will come from the lower personnel costs related to approximately 175 fewer full-time employees in the organization for most of the final three quarters of 2022. Second, lower costs related to outside services, office leases, and other expenses, the majority of which were tied directly or tangentially to SPOCO. And third, our expectation of not having the same level of strategic alternative review process costs as were incurred in 2021. Moving on to capital expenditures, we expect the CapEx will be in the range of $3.4 million to $4.2 million, as the majority of CapEx is related to our wireless business, which is unchanged. Moving to slide eight, as we facilitate our new strategic business plan, we will incur specific one-time restructuring costs. As Vince mentioned earlier, we are trimming approximately one half of our management team and reducing the total employee headcount by approximately one third. And this, of course, is driving the majority of our cost savings in this plan. As a result of these reductions in employee levels, we have estimated severance, retention, and associated personnel costs will be between $5 million and $6.6 million and will be fully incurred in 2022. With the discontinuation of SpokeGo, the company will also incur contractual terminations and exit costs. We will immediately begin the process of working with our SpokeGo customers to ensure that the termination of services is executed as smoothly as possible. As a result, we estimate that the contractual terminations and exit costs related to SpokeGo for both customers and vendors will be between $1.4 million to $3.6 million. Therefore, in total, we are estimating that one-time restructuring costs related to the new business plan will range from $6.4 million to $10.2 million. So moving to slide nine. Now, historically, as a company, we do not provide guidance past one year. But given the uniqueness of the situation for Spoke, I want to share some of our thoughts as we look at the company's preliminary 2023 outlook. So to be clear, this is not guidance, but rather our current thinking on 2023. As I mentioned earlier, fiscal year 2022 is going to be a transition year for the company as we implement our new strategic business plan. With that being said, we expect that the company will be cash flow positive by the third quarter of 2022 and to reach the full cash flow run rate by the end of 2022 as we head into 2023. As for revenue streams, we expect that wireless revenue will continue along current trend levels and have the hope that the addition of our Gen A pager, as Vince discussed earlier, will benefit attrition rates and average revenue per unit. For software revenue, we believe we will begin to stabilize throughout 2022 and 2023 as the company refocuses its sole development efforts on the established Spoke Care Connect suite. Upon the execution of the pivot of this strategic plan, we expect annualized cost savings to be between $40.3 to $44.2 million on a pro forma basis when compared to annualized adjusted operating expenses incurred in the fourth quarter of 2021, less the approximately $1 million of process-related costs. Finally, regarding the $1.25 annual dividend level, based on current expectations, we believe we will be able to fund the majority of this dividend through cash flow from operations. Given the strategic shift, the Board and management believe it is imperative to return our operating cash flow to shareholders and to reduce our existing cash balances in a manner which provides both flexibility during this transition as well as for opportunistic share repurchases, as Vince mentioned earlier. And lastly, as we adopt the plan we have outlined today, It is important to remind investors of the significant deferred tax assets the company has to mitigate federal income tax liabilities going forward. So as we move through this transition, we will continue to update shareholders of our progress. Also, the Board, along with its Capital Allocation Committee, will continue to assess the best way to drive shareholder value from a capital allocation standpoint. With that, I'll turn the call back over to Vince for some closing comments before we open the call up to Q&A.
spk05: Just slide 10, and thank you, Mike. Before we open the call up for questions, I'd like to comment briefly on our business as we move forward. This slide provides an excellent visual of the quality of our healthcare provider customers, which includes some of the top hospitals in the country. For the ninth consecutive year, Smoke has partnered with all 20 of the best adult hospitals, and in eight of the past nine years, the company has also provided solutions to all the best children's hospitals. All these hospital systems rely on spoke to solve complex healthcare communications challenges and provide secure and reliable care team communications, which has been especially important with the rise of COVID-19 variants. We look forward to continuing to provide outstanding support to our customers as we make our business transition. Turning to slide 11, I'd like to wrap up with a quick recap of our business. For starters, We continue to remain committed to our mission to be a strategic partner of choice for enterprise-grade communications and patient care coordination. This commitment has allowed Spoke to create a significant market position with longstanding relationships with the nation's leading healthcare providers. Spoke is a best-in-class paging network, currently the largest in the United States, which continues to generate strong results. And we now have a new, exclusive, alphanumeric messaging device in our Gen A product, Additionally, Spoke continues to provide a valuable and critical service to our customers delivering important information to care teams when and where it matters the most to improve patient outcomes. As previously discussed, our Spoke CareConnect solutions provide a suite of products with potential for new license sales and a valuable maintenance stream. Maintenance continues to provide a foundation under our legacy software business and is important to maintain as we quickly transition to focus on cash flow generation. Finally, I'd like to close by reminding you, Spoke continues to demonstrate a very predictable revenue base, with over 80% of our revenue being recurring in nature, coming from either our legacy wireless offerings or software maintenance contracts. At this point, I'll ask the operator to open the line for questions. Operator?
spk02: At this time, we'll be conducting a question and answer session. If you would like to ask a question, please press star 1 on your telephone keypad. A confirmation symbol indicate your line is in the question queue. You may press star 2 to remove your question from the queue. For participants using speaker equipment, it may be necessary for you to pick up your handset before pressing the star keys. One moment while we poll for questions. Our first question comes from the line of Amelia Roberts with ODN. You may proceed with your question. Hi there.
spk03: Thank you for holding today's call and taking my question. When you rejected the $12 offer almost two years ago, you said that it was not the right time due to disruptions in the debt and equity markets, but also indicated the very recent launch of Spoko and its broad market potential for critical and hospital communications as a growth driver for future company performance. But now you are announcing that you will just continue SoCo. What do you now consider the growth driver for future company performance? And where will we start to see year over year revenue growth?
spk05: Thank you very much for your question. You know, first of all, we are giving guidance today that doesn't suggest revenue growth for 2022. We are very focused on our wireless business, but that is still a trading, albeit it trips a little bit more slowly every year going forward. And our software business has been relatively flat. There's opportunity for revenue growth that would be on the software business side. Last year, our revenue eroded 2% roughly from 2020 levels. And going forward, we expect it to be relatively flat, but there could also be opportunity there because our CareConnect suite, which is our hospital contact center solutions primarily, has not been our primary focus over these last couple years. We haven't put a ton of effort into it. We are the industry leader in that market. And so I think if anywhere in our business there's opportunity for growth, it's going to be there. But we're not forecasting that in our guidance today.
spk03: Okay, great. Thank you. And just to follow up, With that, why would the board agree to make significant changes to dividends and extend employment agreements while still undergoing discussions with bidders for the company? And why would the changes announced today not reduce the chances of other bidders having interest in the company?
spk05: Well, I think the board is importantly focused on the future. And while the process absolutely remains open and the board is open-minded to all potential alternatives to maximize value, we still have a business to run in order to get there. And it's important to make this pivot because the outlook for SpokeGo in this environment with all the pressure that these hospitals have had on their resources, we have found is very difficult. We would have to continue spending at a very high level and hope over the next couple of years that things got better in the healthcare environment. And when we look around and we talk to CIOs and we see what's going on with their resources and how long we think it'll take them to recover, We didn't think continuing to spend $20 million a year in R&D on SpokeGo going forward in the hopes that we would get $2, $5, $10 million of revenue out of it on an annual basis was a good trade. So we made a very difficult decision. As I said in my comments earlier, we did not take this decision lightly. We have an awful lot of good people that worked very, very hard to make this thing successful. It just didn't happen. And so we're left with a very tough slate of choices. The board made the choices. We're moving forward, and we're going to do our absolute best to generate as much cash as we can, and we're going to return that capital to our shareholders. And when we look at our business plan, even with these what we think are conservative outlook, we can pay this level of dividend for a very, very long time, and we can fund most of it through our free cash flow. And so that's what our focus is going to be going forward, and we think it's going to be a very nice yield opportunity. And we think returning capital to shareholders in this environment, given all the things that are happening, given the challenges that we've had with recruiting and retention for engineering talent, given the challenges that we're seeing with respect to M&A going on in the sector and very large competitors moving in. You've seen Oracle acquire Cerner. You saw Stryker acquire Vocera right after Vocera acquired PatientSafe. You saw A while ago, Hill-Rom acquired Volt, who was a competitor of ours, only later for Hill-Rom to get acquired by Baxter. Very large players moving into that clinical communication space. All these were factors in our decision to make the changes that we made. And we think going forward, running the company for cash flow, returning that cash to our shareholders, doing selective share repurchases, while keeping a completely open mind to other alternatives to maximize shareholder value and is the right business plan at this point.
spk02: Okay, great. Thank you. Our next question comes from the line of Jason Craft, private investor. You may proceed with your question.
spk06: Hey, it's Jason Craft with Highcliffe Capital. I got a few questions. So now that board and management have come to terms with running the two business segments for cash, You've given some outlook in the guidance, but let's get some color on just where you think the free cash flow margins of both segments could look like, say, on a run rate end of the year or next year. And you've given the guidance on some of the cost and the revenue, but let's talk about what really matters to cash flow. So what are the free cash flow margin expectations on both segments?
spk05: Yeah, we didn't provide guidance on free cash flow margin expectations. We said we'd cover the majority of the dividend through free cash flow next year.
spk06: and going forward and that's all the guidance we're going to give regarding that today we'll take a look in the future if we want to give additional guidance around that but not today but vince i mean we're in a we're in a different mode here where you guys just to be blunt we hear a lot about maximizing shareholder value maximizing free cash flow there really is no there really hasn't been a track record in that and the board as well as management team has no credibility in saying something like that. So I think we're in a mode where I think it's incumbent on you guys to lay out what you think those margins are. A lot of us shareholders, we think we know, and you guys spent shareholder capital for the last seven months to come to conclusion that many of us realized the path you were heading down well before that. So I think we appreciate some of the transparency, but I think it's a and coming on you guys and start laying out what you think these assets really can drive in terms of cash, you know, in the pager business as well as the software.
spk05: Yeah, let me – two things to respond to that. First of all, I want to correct your record in terms of management credibility and being able to do this. We've generated a billion dollars of free cash flow since we've been doing this, and we've returned the overwhelming majority of that to shareholders, okay? So what you're really talking about is just spoke go. And we've run into a very tough scenario with SpokeGo with respect to what this pandemic did. And so I think we made the right business decision, and I think we have a track record of selling off an enormous amount of cash. And you watch us. We'll do so. I don't know, Mike, if you want to comment on the margin.
spk04: Yeah, a couple of things, Jason, on the free cash flow margin. You know, as you said, you could back into a lot of the numbers. We have specifically – said that we could cover a majority of that $1.25 annual dividend. We think that that number is going to be about 75% to 80%, which is about $1 a share at the end of the day. So that translates to about a 15% to 17% free cash flow margin on the business. But we need to make this transition during this year. So those numbers can certainly change, and we hope that they would actually obviously go up.
spk06: So 15% to 17% in aggregate on the business towards the end of the year. If you segment out, if we just listed the pageant business, does the pageant business have higher free cash flow margins than the software business at the moment?
spk05: Yeah, we're not. We don't do segment accounting.
spk04: And the other point, Jason, is that that 15% to 17% free cash flow margin is a run rate basis. Right. think after we get through this transition on a run rate basis, which we think we'll certainly be at by the end of 2022, you would be at those free cash flow margins.
spk06: And then just real quick, because you brought it up, Vince, on the billion of cash. Yeah. You can generate all the cash in the world, but if it doesn't, if you're a publicly traded equity and it doesn't reflect actual total shareholder returns, it doesn't matter.
spk05: Well, I mean, $623 million or so of it has been returned to shareholders. That's money that's like $30 a share or something that they've gotten cash from us over the years. So, yeah. And look, you know, we said today, you know, Jason, we said today we're taking out between, I mean, you know, midpoint $42 million of operating expenses on a run rate basis. That's a lot of costs that's being reduced. And I think each quarter going forward, you'll see. and it'll be much more clear what the cash flow potential, what the margin potential of this company is. But it is something that we've done before to great success. It's something that we're very focused on right now. It's unfortunate that we've come to this, but it's the best conclusion we have. And we also have an ongoing process, I'll remind you, so that's keeping us a little bit busy too.
spk02: As a reminder, if you would like to ask a question, please press star 1 on your telephone keypad. Ladies and gentlemen, we have reached the end of today's question and answer session. I would like to turn this call back over to Mr. Vincent Kelly for closing remarks.
spk05: Thank you very much, everyone, for joining us today, and thanks for your patience during this lengthy process. We appreciate your support and your interest in SPOKE. We look forward to updating everybody again next quarter. If you have any additional questions, please reach out to our investor relations team at and we'll follow back up with you. Everyone have a great day, and please stay safe and stay healthy.
Disclaimer